Related Experiment Video
Updated: Nov 24, 2025

08:58
Fully Automated Centrifugal Microfluidic Device for Ultrasensitive Protein Detection from Whole Blood
Published on: April 16, 2016
10.8K
Highly efficient and scalable biomarker preconcentrator based on nanoelectrokinetics.
Dohwan Lee1, Jee Won Lee2, Cheonjung Kim1
1Department of Electrical Engineering, Kwangwoon University, Seoul, 01897, Republic of Korea.
Biosensors & Bioelectronics
|December 22, 2020
Summary
This study introduces a microfluidic paper-based device for large-volume biomarker preconcentration from samples like human serum. The novel approach efficiently enriches biomarkers, overcoming volume limitations in microfluidics for diagnostics.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Materials Science
Background:
- Micro/nanofluidics offer potential for biological sample preparation but are limited by small processing volumes.
- Current microfluidic systems typically handle sample volumes in the microliter range, restricting applications for large samples.
- Efficiently processing larger sample volumes is crucial for practical biomarker analysis and diagnostics.
Purpose of the Study:
- To develop a microfluidic paper-based large-volume preconcentrator (u-LVP) for biomarker enrichment and purification.
- To overcome the sample volume limitations inherent in conventional microfluidic devices.
- To enable efficient isolation and concentration of biomarkers like miRNA from complex biological samples.
Main Methods:
- Utilized a Nafion-functionalized multilayer cellulose paper for microscale sample division and ion concentration polarization.
- Employed electrokinetic separation to isolate and preconcentrate biomarkers within the microfluidic paper device.
- Integrated collecting discs for simple and high-efficiency recovery of the enriched biomarkers.
Main Results:
- Demonstrated successful separation and preconcentration of miRNA-21 from human serum, effectively removing proteins.
- Achieved an effective preconcentration factor exceeding 6.63 for miRNA-21.
- Obtained a recovery rate above 84% for the targeted biomarker.
Conclusions:
- The developed microfluidic paper-based large-volume preconcentrator (u-LVP) effectively addresses sample volume limitations in microfluidics.
- This platform offers a promising solution for biomarker enrichment and purification, enhancing diagnostic and prognostic research.
- The u-LVP technology presents new opportunities for biomarker discovery, diagnostics, and therapeutic applications.

